IL90427A - Peptide-containing pharmaceutical compositions having use for treatment of neuropsychiatric deficits - Google Patents

Peptide-containing pharmaceutical compositions having use for treatment of neuropsychiatric deficits

Info

Publication number
IL90427A
IL90427A IL9042789A IL9042789A IL90427A IL 90427 A IL90427 A IL 90427A IL 9042789 A IL9042789 A IL 9042789A IL 9042789 A IL9042789 A IL 9042789A IL 90427 A IL90427 A IL 90427A
Authority
IL
Israel
Prior art keywords
thr
ala
formula
cys
linear peptide
Prior art date
Application number
IL9042789A
Other languages
English (en)
Original Assignee
Us Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/352,313 external-priority patent/US5063206A/en
Application filed by Us Health filed Critical Us Health
Publication of IL90427A publication Critical patent/IL90427A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
IL9042789A 1988-05-27 1989-05-26 Peptide-containing pharmaceutical compositions having use for treatment of neuropsychiatric deficits IL90427A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19987388A 1988-05-27 1988-05-27
US28555988A 1988-12-16 1988-12-16
US07/352,313 US5063206A (en) 1988-12-16 1989-05-16 Compositions having use as treatment of neuropsychiatric deficits

Publications (1)

Publication Number Publication Date
IL90427A true IL90427A (en) 1994-10-07

Family

ID=27394077

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9042789A IL90427A (en) 1988-05-27 1989-05-26 Peptide-containing pharmaceutical compositions having use for treatment of neuropsychiatric deficits

Country Status (8)

Country Link
EP (1) EP0415999B1 (de)
JP (2) JPH0618777B2 (de)
AT (1) ATE168698T1 (de)
AU (1) AU620107B2 (de)
CA (1) CA1336677C (de)
DE (1) DE68928752T2 (de)
IL (1) IL90427A (de)
WO (1) WO1989012067A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6242564B1 (en) * 1986-06-03 2001-06-05 Candace B. Pert Treatment of tropical spastic paresis with peptide T
US5189022A (en) * 1988-05-27 1993-02-23 The United States Of America As Represented By The Secretary Of Health And Human Services Composition for the treatment of chronic fatigue syndrome
DK31991D0 (da) * 1991-02-25 1991-02-25 Carlbiotech Ltd As Peptid og farmaceutisk praeparat indeholdende et saadant peptid
US6011014A (en) * 1992-03-27 2000-01-04 Advanced Immunit, Inc. Peptide T and related peptides in the treatment of inflammation, including multiple sclerosis
ZA932233B (en) * 1992-03-27 1994-09-29 Peptide Technology Ltd Peptide T and related peptides in the treatment of inflammation including multiple sclerosis
ES2149203T3 (es) * 1992-03-27 2000-11-01 Advanced Immunit T Inc Peptido t y peptidos asociados destinados para el tratamiento de las inflamaciones, particularmente la esclerosis multiple.
DK0871466T3 (da) * 1993-09-24 2004-08-16 Advanced Immuni T Inc Lineære og cykliske peptider til behandling eller forebyggelse af eksem/dermatitis
EP0729360B1 (de) * 1993-09-24 2004-05-26 Advanced Immuni T, Inc. Lineare und cyklische peptide zur behandlung oder vorbeugung der crohn'schen krankheit und/oder der ulzerativen kolitis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5921613A (ja) * 1982-07-28 1984-02-03 Takeda Chem Ind Ltd 直腸投与製剤
WO1987007614A1 (en) * 1986-06-03 1987-12-17 Pert Candace B Small peptides which inhibit binding to t-4 receptors
EP0249394B1 (de) * 1986-06-03 1993-10-27 THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce Kleine Peptide, die die Bindung an T-4-Rezeptoren inhibieren und als Immunogene wirken
US4804651A (en) * 1987-06-09 1989-02-14 Board Of Regents, The University Of Texas System Methods and compositions for the treatment of psoriasis
PT90657B (pt) * 1988-05-27 1995-03-01 Ortho Pharma Corp Processo para a preparacao de peptidos que bloqueiam a ligacao de hiv-1 a proteina cd4 receptora

Also Published As

Publication number Publication date
AU620107B2 (en) 1992-02-13
JPH06228001A (ja) 1994-08-16
EP0415999A4 (en) 1991-10-16
EP0415999A1 (de) 1991-03-13
JP3011837B2 (ja) 2000-02-21
CA1336677C (en) 1995-08-15
DE68928752T2 (de) 1998-12-03
JPH0618777B2 (ja) 1994-03-16
ATE168698T1 (de) 1998-08-15
DE68928752D1 (de) 1998-08-27
AU3693689A (en) 1990-01-05
WO1989012067A1 (en) 1989-12-14
EP0415999B1 (de) 1998-07-22
JPH03502928A (ja) 1991-07-04

Similar Documents

Publication Publication Date Title
SWANSON et al. Myoclonus—a report of 67 cases and review of the literature
US5063206A (en) Compositions having use as treatment of neuropsychiatric deficits
West The pharmacology and therapeutics of curare and its constituents
CN103270022A (zh) 神经营养蛋白受体激动剂及其作为药物的应用
ATE87484T1 (de) Physiologisch aktive substanzen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
IL90427A (en) Peptide-containing pharmaceutical compositions having use for treatment of neuropsychiatric deficits
AU663875B2 (en) Compositons for the treatment of chronic fatigue syndrome
FI96865C (fi) Menetelmä terapeuttisesti käyttökelpoisen, olennaisesti puhtaan polypeptidin valmistamiseksi
Naftchi Functional restoration of the traumatically injured spinal cord in cats by clonidine
McComas et al. Motoneurone dysfunction in patients with hemiplegie atrophy
IL105822A (en) Pharmacy products for use in the treatment of tropical spasticity
US5248667A (en) Method of treating psoriasis using synthetic peptide compositions
US5534495A (en) Treatment of non-HIV neuropathic pain syndromes
JP3520084B2 (ja) 多発性硬化症を含めた炎症の治療におけるペプチドｔ及びその関連ペプチド類
EP1075270B1 (de) Kurzes peptid zur behandlung neurodegenerativer erkrankungen
RU2288716C2 (ru) Нейротропные аналоги такролимуса
Lebedyeva et al. Ionic conjugates of lidocaine and sweeteners as better tasting local anesthetics for dentistry
WO1999018123A1 (fr) Utilisation des bloqueurs des canaux potassium neuronaux et lymphocytaires dans le traitement des maladies neurologiques d'origine immunitaire
CN110357950A (zh) 酸性氨基酸扫描法设计的免疫抑制多肽及应用
Bennett The introduction of curare into clinical medicine: present and potential usefulness
JP2000500156A (ja) ヒルから得られる抗ウイルス性単離物
Wu et al. POSTER COMMUNICATIONS
HARRISON et al. of descending monosynaptic excitatory post-synaptic potentials in cat spinal motoneurones

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
KB Patent renewed